Francine MD - Senseonics Holdings Chief Director

Senseonics Holdings Management Efficiency

The company has return on total asset (ROA) of (0.3873) % which means that it has lost $0.3873 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.458) %, meaning that it created substantial loss on money invested by shareholders. Senseonics Holdings' management efficiency ratios could be used to measure how well Senseonics Holdings manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.46 in 2024. Return On Capital Employed is likely to drop to -0.66 in 2024. At this time, Senseonics Holdings' Non Current Assets Total are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 7.6 M in 2024, whereas Non Currrent Assets Other are likely to drop slightly above 1.2 M in 2024.

Similar Executives

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring systems for people with diabetes in the United States, Europe, the Middle East, and Africa. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. Senseonics Holdings operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 89 people. Senseonics Holdings (SENS) is traded on NYSE MKT Exchange in USA. It is located in 20451 Seneca Meadows Parkway, Germantown, MD, United States, 20876-7005 and employs 132 people. Senseonics Holdings is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Senseonics Holdings Leadership Team

Senseonics Stock Performance Indicators

Additional Tools for Senseonics Stock Analysis